| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 132, 345-355, Copyright © 1988 by American Society for Investigative Pathology
REGULAR ARTICLES |
UM Wewer, R Albrechtsen, LW Fisher, MF Young and JD Termine
University Institute of Pathological Anatomy, Copenhagen, Denmark.
The identification and cDNA cloning of bone-enriched osteonectin and parietal endoderm-enriched SPARC indicated that these proteins share greater than 90% homology. The present study reports substantial expression of this Mr 43,000 protein in human decidua and carcinoma. Metabolic labeling of human decidua tissue in organ culture demonstrated significant osteonectin biosynthesis. Further, Northern analysis and in situ hybridization showed that the osteonectin mRNA level in human decidua is very high. Immunohistochemically, the large mature decidual cells exhibited faint cytoplasmic immunoreactivity with antibodies to osteonectin and a distinct immunoreactivity of the newly deposited basement membranes encircling these cells. The intermediate- sized decidual cells exhibited a strong cytoplasmic immunostaining with antibodies to osteonectin. The small elongated stromal cells were devoid of osteonectin immunoreactivity. Blood vessels exhibited variable positive immunoreactivity. The osteonectin expression in 38 cases of human carcinomas was examined. In well-differentiated carcinomas osteonectin immunoreactivity was located in the basement membrane area, codistributing with laminin. Cytoplasmic osteonectin immunoreactivity was found in poorly differentiated carcinomas. Stromal cells in the peritumoral tissue and some vessels were immunoreactive. Using in situ hybridization, it appeared that both the tumor cells and the stromal cells contained osteonectin transcripts. In normal steady state human nonosseus tissues investigated, osteonectin was found inconsistently in the basement membranes only, as based on the present immunohistochemical technique. These results suggest that the osteonectin/SPARC gene appears activated in certain human tissues characterized by de novo formation of basement membrane.
This article has been cited by other articles:
 |
|
 |
|
  N. Martinek, J. Shahab, M. Saathoff, and M. Ringuette Haemocyte-derived SPARC is required for collagen-IV-dependent stability of basal laminae in Drosophila embryos J. Cell Sci., May 15, 2008; 121(10): 1671 - 1680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lotinun, J. D. Sibonga, and R. T. Turner Evidence that the Cells Responsible for Marrow Fibrosis in a Rat Model for Hyperparathyroidism Are Preosteoblasts Endocrinology, September 1, 2005; 146(9): 4074 - 4081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sangaletti, L. Gioiosa, C. Guiducci, G. Rotta, M. Rescigno, A. Stoppacciaro, C. Chiodoni, and M. P. Colombo Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice J. Cell Sci., August 15, 2005; 118(16): 3685 - 3694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bini, K. G. Mann, B. J. Kudryk, and F. J. Schoen Noncollagenous Bone Matrix Proteins, Calcification, and Thrombosis in Carotid Artery Atherosclerosis Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1852 - 1861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-L. Xie and G. L. Long Elements within the First 17 Amino Acids of Human Osteonectin Are Responsible for Binding to Type V Collagen J. Biol. Chem., April 5, 1996; 271(14): 8121 - 8125. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
